XTANT MEDICAL HOLDINGS, INC. Impairment Charge on Reclassified Assets
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Impairment Charge on Reclassified Assets of $1.60 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-04-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentChargeOnReclassifiedAssets · last filed 2019-04-01
- XTANT MEDICAL HOLDINGS, INC. impairment charge on reclassified assets for fiscal 2017 was $1.60M.
| Period end | Impairment Charge on Reclassified Assets 12 month |
|---|---|
| 2017-12-31 | $1.60M 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |